EcoDrugPlus

Ensembl ID : ENSSPAG00000021064
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSSPAG00000020986
Gene Symbol: -
1 Cross references
401 Possible Orthologues:

Ensembl ID : ENSSPAG00000020977
Gene Symbol: -
1 Cross references
346 Possible Orthologues:

Ensembl ID : ENSSPAG00000020968
Gene Symbol: -
Cross references: -
346 Possible Orthologues:

Ensembl ID : ENSSPAG00000020236
Gene Symbol: -
Cross references: -
140 Possible Orthologues:

Ensembl ID : ENSSPAG00000002597
Gene Symbol: -
Cross references: -
144 Possible Orthologues:

Ensembl ID : ENSSPAG00000022841
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSSPAG00000019424
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSSPAG00000022969
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSSPAG00000017475
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSSPAG00000016954
Gene Symbol: -
Cross references: -
530 Possible Orthologues:

Ensembl ID : ENSSPAG00000016016
Gene Symbol: -
Cross references: -
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).